Top compounds associated with response to OXTR


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA MS-275 CTRPv2 pan-cancer AAC -0.08 0.02
mRNA parbendazole CTRPv2 pan-cancer AAC -0.076 0.02
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.13 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.02
mRNA Mitomycin-C GDSC1000 pan-cancer AAC -0.086 0.02
mRNA narciclasine CTRPv2 pan-cancer AAC -0.081 0.02
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.076 0.02
mRNA tivantinib CTRPv2 pan-cancer AAC -0.12 0.02
Download CSV